Sina Zargham

Dr. Sina Zargham

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
PSPaniz Sabeghi
Paniz Sabeghi
PZPaniz Zarand
Paniz Zarand
SZSina Zargham
Sina Zargham
BGBatis Golestany
Batis Golestany
ASArya Shariat
Arya Shariat
AGAli Gholamrezanezhad
Ali Gholamrezanezhad
This study delineates the pivotal role of imaging within the field of neurology, emphasizing its significance in the diagnosis, prognostication, and evaluation of treatment responses for central nervous system (CNS) tumors. A comprehensive understanding of both the capabilities and limitations inherent in emerging imaging technologies is imperative for delivering a heightened level of personalized care to individuals with neuro-oncological conditions. Ongoing research in neuro-oncological imaging endeavors to rectify some limitations of radiological modalities, aiming to augment accuracy and efficacy in the management of brain tumors. This review is dedicated to the comparison and critical examination of the latest advancements in diverse imaging modalities employed in neuro-oncology. The objective is to investigate their respective impacts on diagnosis, cancer staging, prognosis, and post-treatment monitoring. By providing a comprehensive analysis of these modalities, this review aims to contribute to the collective knowledge in the field, fostering an informed approach to neuro-oncological care. In conclusion, the outlook for neuro-oncological imaging appears promising, and sustained exploration in this domain is anticipated to yield further breakthroughs, ultimately enhancing outcomes for individuals grappling with CNS tumors.

1 July 2025 in JBJS Case Connector
Verified
Journal Article
Closed access
AGAshleigh Gibula
Ashleigh Gibula
AMArya Minaie
Arya Minaie
SZSina Zargham
Sina Zargham
JJJean Jose
Jean Jose
SSSteven Steinlauf
Steven Steinlauf
AMAnnabella Mikki
Annabella Mikki
Case: We present the case of a 28-year-old female professional ballet dancer with a complex 3-level Achilles tendon injury where preoperative ultrasound was used to guide incision placement. With limited incisions, the patient underwent successful 3-level repair and has returned to dancing. Conclusion: This was a rare case of a magnetic resonance imaging–-confirmed 3-level acute Achilles tendon injury. Point-of-care ultrasound in the preoperative holding area was used for precise marking of each level allowing a minimally invasive surgical approach rather than a single, large incision. Multiple imaging modalities can be used to guide the surgical management of and limit incision size of complex injuries that otherwise may seem straightforward.

26 May 2023 in AJPM Focus
Verified
Journal Article
Open access
TGTara L. Gallant
Tara L. Gallant
AGAndrew R. Gilbert
Andrew R. Gilbert
SZSina Zargham
Sina Zargham
MLMichael F. Di Lorenzo
Michael F. Di Lorenzo
JPJosé Luis Puglisi
José Luis Puglisi
VGValerie Gerriets
Valerie Gerriets
Ensuring that people at risk of overdosing on opioids have easy access to naloxone is an essential part of the fight against the opioid crisis. This study evaluates the impact of the 2016 California law (CA AB1535) permitting pharmacies to dispense this life-saving medication without a physician's prescription. California counties were categorized on the basis of population density (rural, suburban, urban), rate of opioid-related deaths by population density (high, medium, low), and rate of opioid prescriptions by population density (high, medium, low). Ten diverse pharmacies from each category were selected for inclusion. In a brief 1-minute interview conducted between July and August 2021, pharmacists from 146 California pharmacies were surveyed regarding their knowledge of CA AB1535, their practice of dispensing naloxone without a physician's prescription, and whether they normally stock naloxone. Chi-square tests were used to compare responses. Although almost all pharmacies interviewed (94%) were aware of the law and most of them (64%) dispensed naloxone without a physician's prescription, few statistically significant differences were found between surveyed categories. There were no significant relationships between naloxone availability at pharmacies and overdose death rates. Our results suggest that the number of California pharmacies dispensing naloxone without a physician's prescription has continued to increase since the implementation of CA AB1535. However, despite increased access to naloxone at pharmacies, opioid overdose rates have continued to rise since 2016, indicating the need for a multifaceted harm reduction approach.